RAVICTI- long term ammonia control for all ages
Original price was: £600.00.£500.00Current price is: £500.00.
Ravicti (glycerol phenylbutyrate) is a member of the urea cycle disorder agents drug class and is commonly used for Urea Cycle Disorders. The cost for Ravicti (1.1 g/mL) oral liquid is around £6,003 for a supply of 25 milliliters, depending on the pharmacy you visit.
Free shipping on orders over $5500!
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
RAVICTI is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (UCDs) – who cannot be managed by dietary protein restriction and/or amino acid supplementation alone – including deficiencies of:1
carbamoyl phosphate-synthase-I (CPS)
ornithine carbamoyltransferase (OTC)
argininosuccinate synthetase (ASS)
argininosuccinate lyase (ASL)
arginase I (ARG)
ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (HHH)
Ravicti (glycerol phenylbutyrate) logo
Menu
RAVICTI® – long term ammonia control for all ages
RAVICTI® (glycerol phenylbutyrate) is a treatment used to treat patients of all ages with UCDs. The medicine is used to reduce the amount of ammonia in the blood in order to reduce the risk of neurological consequences.1 RAVICTI is an oral liquid, which means it´s taken by mouth. It is usually taken 3* times a day by oral syringe in equal doses. It must be used with dietary protein restriction and, in some cases, dietary supplements.1
RAVICTI is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (UCDs) – who cannot be managed by dietary protein restriction and/or amino acid supplementation alone – including deficiencies of:1
carbamoyl phosphate-synthase-I (CPS)
ornithine carbamoyltransferase (OTC)
argininosuccinate synthetase (ASS)
argininosuccinate lyase (ASL)
arginase I (ARG)
ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (HHH)
Ravicti (glycerol phenylbutyrate) oral liquid bottle
RAVICTI is:
approved for all ages, including from newborn1
designed to enable slow release of phenylbutyrate into the circulation1
the only UCD treatment that has been shown to provide sustained ammonia control in both short term (2 weeks) and long-term (12 months) in prospective studies1
sodium and sugar free1
designed to facilitate easy administration and adherence to treatment
nearly tasteless and odourless oral liquid2
convenient low volume dosing 3* times daily1
Reviews
There are no reviews yet.